Related references
Note: Only part of the references are listed.Expression, purification, and characterization of recombinant human β-amyloid42 peptide in Escherichia coli
Li Zhang et al.
PROTEIN EXPRESSION AND PURIFICATION (2009)
Structural Classification of Toxic Amyloid Oligomers
Charles G. Glabe
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Aggregation and catabolism of disease-associated intra-Aβ mutations:: reduced proteolysis of AβA21G by neprilysin
Vicki Betts et al.
NEUROBIOLOGY OF DISEASE (2008)
Characterization of amyloid ß peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry
Erik Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma:: Evidence for novel Aβ species
Juan Manuel Maler et al.
PROTEOMICS (2007)
Purification of recombinantly expressed and cytotoxic human amyloid-beta peptide 1-42
Katja Wiesehan et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Synthesis of Aβ(1-42) and its derivatives with improved efficiency
Marta Zarandi et al.
JOURNAL OF PEPTIDE SCIENCE (2007)
Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment
Annika Thorsell et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2007)
A beta Oligomers - a decade of discovery
Dominic M. Walsh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Solution state characterization of amyloid β-derived diffusible ligands
Robert W. Hepler et al.
BIOCHEMISTRY (2006)
Presenilin clinical mutations can affect γ-secretase activity by different mechanisms
M Bentahir et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Expression and purification of a recombinant peptide from the Alzheimer's β-amyloid protein for solid-state NMR
S Sharpe et al.
PROTEIN EXPRESSION AND PURIFICATION (2005)
Production of recombinant amyloid-β peptide 42 as an ubiquitin extension
EK Lee et al.
PROTEIN EXPRESSION AND PURIFICATION (2005)
Amyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry:: Evidence of novel biomarkers in Alzheimer's disease
P Lewczuk et al.
BIOLOGICAL PSYCHIATRY (2004)
Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment:: Indication of carrier-mediated epitope masking of amyloid β peptides
M Bibl et al.
ELECTROPHORESIS (2004)
Removal of N-terminal methionine from recombinant proteins by engineered E-coli methionine aminopeptidase
YD Liao et al.
PROTEIN SCIENCE (2004)
Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease - Original data and review of the literature
P Lewczuk et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2004)
Electrophoretic separation of amyloid β peptides in plasma
P Lewczuk et al.
ELECTROPHORESIS (2004)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Improved preparation of amyloid-β peptides using DBU as Nα-Fmoc deprotection reagent
AK Tickler et al.
JOURNAL OF PEPTIDE SCIENCE (2001)
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
C Nilsberth et al.
NATURE NEUROSCIENCE (2001)
In vitro studies of amyloid β-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692 → Gly) Alzheimer's disease
DM Walsh et al.
BIOCHEMICAL JOURNAL (2001)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
Share Paper
